Tesamorelin Dosage

Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.

Usual Adult Dose for Lipodystrophy

2 mg subcutaneously once a day

Comments:

• Long term cardiovascular safety and benefit have not been studied.
• Not indicated for weight loss (weight neutral effect).
• There are no data to support improved compliance with anti-retroviral therapies in HIV positive patients.

Use(s): Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

• Disruption of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation, or head trauma
• Active malignancy (newly diagnosed or recurrent)
• Hypersensitivity to tesamorelin and/or mannitol (an excipient)
• Pregnancy

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• Administer into abdominal skin subcutaneously, rotating sites.
• Do not inject into scar tissue, bruises, or the navel.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer